Literature DB >> 21960848

Pharmacogenomics of IBD Therapies.

Themistocles Dassopoulos1.   

Abstract

Year:  2007        PMID： 21960848      PMCID： PMC3099313     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study.

Authors:  Edouard J Louis; Hervé E Watier; Stefan Schreiber; Jochen Hampe; François Taillard; Allan Olson; Nicole Thorne; Hongyan Zhang; Jean-Frédéric Colombel
Journal:  Pharmacogenet Genomics       Date:  2006-12       Impact factor: 2.089

2.  Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.

Authors:  Fady Daniel; Marie-Anne Loriot; Philippe Seksik; Jacques Cosnes; Jean-Marc Gornet; Marc Lémann; Francine Fein; Gwenola Vernier-Massouille; Martine De Vos; Arnaud Boureille; Xavier Treton; Bernard Flourié; Xavier Roblin; Edouard Louis; Frank Zerbib; Philippe Beaune; Philippe Marteau
Journal:  Inflamm Bowel Dis       Date:  2007-01       Impact factor: 5.325

3.  High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.

Authors:  R J Farrell; A Murphy; A Long; S Donnelly; A Cherikuri; D O'Toole; N Mahmud; P W Keeling; D G Weir; D Kelleher
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

Review 4.  Pharmacogenomics and individualized drug therapy.

Authors:  Michel Eichelbaum; Magnus Ingelman-Sundberg; William E Evans
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

5.  6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease.

Authors:  Markus F Neurath; Ralf Kiesslich; Ute Teichgräber; Christine Fischer; Ute Hofmann; Michel Eichelbaum; Peter R Galle; Matthias Schwab
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

6.  Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.

Authors:  Carmen Cuffari; Themistocles Dassopoulos; Lisa Turnbough; Richard E Thompson; Theodore M Bayless
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382

7.  Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.

Authors:  E Louis; Z El Ghoul; S Vermeire; S Dall'Ozzo; P Rutgeerts; G Paintaud; J Belaiche; M De Vos; A Van Gossum; J-F Colombel; H Watier
Journal:  Aliment Pharmacol Ther       Date:  2004-03-01       Impact factor: 8.171
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.